-----Original Message-----
From: GTCbio Conferences [mailto:[log in to unmask]]
Sent: Tuesday, May 09, 2006 5:29 AM
To: Orten, Dana J
Subject: 2nd Metabolic Diseases World Summit - Handbook Preview
2nd Metabolic Diseases World Summit
- Handbook Preview -
May 18-21, 2006, Long Beach, California
http://gtcbio.com/confpage.asp?cid=17 http://gtcbio.com/confpage.asp?cid=17
Dear Colleague,
There are less than two weeks left to sign up to attend the 2nd Annual
Metabolic Diseases World Summit on May 18-21, 2006 taking place in Long
Beach, CA. Pioneers in the field will present on novel research and data in
metabolic diseases at this four-day summit. We would like to invite you to
preview a sample of the talks which will talk place during the event. The
PDF file will be available for viewing or downloading until May 10th. Please
visit http://www.gtcbio.com/previews/MetabolicPreview.pdf
http://www.gtcbio.com/previews/MetabolicPreview.pdf
for your copy. The agenda is also available online at
http://gtcbio.com/program.asp?cid=17 http://gtcbio.com/program.asp?cid=17
.
PRESENTERS INCLUDE:
Doug Greene, Ph.D., Keynote Speaker, Vice President, Corporate Regulatory
Affairs, Head, Regulatory Development Department, SANOFI-AVENTIS Richard Ho,
Ph.D., Head, Medical Informatics, Johnson & Johnson Pharmaceutical R&D Peer
Jacobson, Ph.D., Project Leader, Metabolic Disease Research, Abbott
Laboratories Joseph S. Grimsby, Ph.D., Sr. Research Leader, Metabolic
Diseases, F. Hoffmann-La Roche
Ming Wang, M.D., Department of Metabolic Disorders, Amgen Inc.
David Erbe, Ph.D., Cardiovascular and Metabolic Diseases, Wyeth Research Lori
Gowen Morton, Staff Scientist, Regeneron Pharmaceuticals
Rolf Thierringer, Department of Cardiovascular Diseases, Merck Research
Laboratories John Holcombe, M.D., Medical Fellow, US Diabetes Care, Eli Lilly
& Company Anne Reifel Miller, Ph.D., Eli Lilly & Company
Daniel J. Wilson, M.D., Director, Regional Medical Research Specialist
Cardiovascular, Pfizer Inc.
David G. Parkes, Ph.D., Senior Director, Research, Amylin Pharmaceuticals
John P. Mayer, Ph.D., Eli Lilly & Company
Wick Johnson, Ph.D., Director, Licensing and Development, Pfizer Incorporated
Linda Egger, Ph.D., Assoc. Director, Scientific Liaison, External Scientific
Affairs, Merck & Co., Inc.
Robert Mashal, President & CEO,
Alinea Pharmaceuticals
Harold Wright, Director, Biology,
CytRx Corporation
Dan Einhorn, Head,
Scripps Whittier Diabetes Institute
John Gerich, M.D., Clinical Research Center, University of Rochester School
of Medicine
Paresh Dandona, M.D., Professor of Medicine, University of Buffalo David
Bell, M.D., Endocrinologist, University of Alabama at Birmingham School of
Medicine Grant Barish, M.D., Howard Hughes Medical Inst., Gene Expression
Lab, Salk Inst. for Biological Studies
Lois Jovanovic,
Sansum Diabetes Research Institute
Jean Claude Desmangles,
Creighton University
John Rodzvilla, M.D.,
Auxilium Pharmaceuticals
Marc Rendell, M.D., (Conference Chair)
Creighton University School of Medicine
Joel Ray, M.D., Assist. Prof. & Clinician Scientist, Div. of Endo. & Met.,
University of Toronto Bernice Welles, M.D., MBA, VP, Development, DiObex To
register, visit http://www.gtcbio.com/ www.gtcbio.com or call 626-256-6405.
Other Upcoming Conferences:
Assay Development & High-throughput Screening June 22-23, 2006 - San
Francisco, CA Therapeutic Strategies against Neurodegenerative Conditions
http://gtcbio.com/confpage.asp?cid=19
September 18 & 19, 2006
Epigenetic and Neural Development Disorders September 18 & 19, 2006
Partnering, Licensing & Alliance Management for Neuro-focused Organizations
September 19th, 2006 3rd Annual Tumor Progression & Therapeutic Resistance
Oct 22-24, 2006 - Baltimore, MD Immunodiagnostic and Immunomonitoring: From
Research to Clinic November 5-7, 2006 - San Diego, CA 4th conference on
Vaccines: All Things Considered November 16-17, 2007 - Washington DC 2nd
Modern Drug Discovery & Development Summit December 4-6, 2006 - Pennsylvania
Convention Center, Philadelphia, PA This summit will including the following
11 conferences:
1. Systems Biology in Drug Discovery
2. Model Organisms in Drug Discovery
3. CNS Diseases and Drug Discovery
4. Nanobiotechnology in Drug Discovery 5. Antibodies Discovery and
Development 6. Drug Delivery Technology 7. Medicinal Chemistry 8.
Epigenetic Cancer Therapy 9. Stem Cell Research and Regenerative Medicine
10. Drug Safety and Pharmacovigilance 11. Biotech and Pharmaceutical
Licensing and Deal-Making Visit http://www.gtcbio.com/ www.gtcbio.com for
details.
This advertisement comes to you from GTCbio, 434 W. Foothill Blvd, Monrovia,
CA 91016. To update your contact information, please
http://gtcbio.com/feedback.asp click here . If you prefer not to receive
further messages from this sender,
http://www.biofacilitator.com/MassMail/RequestProcessed.aspx?Id=Qyp3Z0iYz9%2f
Axy2qXbuyrw%3d%3d&EmailId=jDsCfk2M9M12kmXWbo2M7%2fzhv1MQzLiP3AS2wykHqq0%3d
Click To Remove your name from the mailing list. If your browser doesn't
allow you to use the removal link, please copy and paste the following into
your browser and hit enter.
http://www.biofacilitator.com/MassMail/RequestProcessed.aspx?Id=Qyp3Z0iYz9%2f
Axy2qXbuyrw%3d%3d&EmailId=jDsCfk2M9M12kmXWbo2M7%2fzhv1MQzLiP3AS2wykHqq0%3d
|
